Pediatrix Medical Group, Inc. (MD) stock
MDNYSEServices-HospitalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/307% above fair value
$31.40−0.05 (-0.16%)
Close on Nov 12, 2026Market cap $2.45BP/E 17.1Yield –
Pediatrix Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Pediatrix Medical's profit margin for the twelve months ending Sep 30, 2026 was 7.7%. For fiscal 2025 it was 8.6%, against -4.9% the year before. The highest annual figure on record is 15.6% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.6% | +13.6 |
| FY2024 | Dec 31, 2024 | -4.9% | −1.9 |
| FY2023 | Dec 31, 2023 | -3.0% | −6.4 |
| FY2022 | Dec 31, 2022 | 3.4% | −3.5 |
| FY2021 | Dec 31, 2021 | 6.9% | +52.8 |
| FY2020 | Dec 31, 2020 | -45.9% | +38.2 |
| FY2019 | Dec 31, 2019 | -84.2% | −99.7 |
| FY2018 | Dec 31, 2018 | 15.6% | +5.7 |
| FY2017 | Dec 31, 2017 | 9.8% | −0.4 |
| FY2016 | Dec 31, 2016 | 10.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 9.4% | −5.2 |
| Q2 FY2026 | Jun 30, 2026 | 8.2% | −0.2 |
| Q1 FY2026 | Mar 31, 2026 | 6.2% | +1.7 |
| Q4 FY2025 | Dec 31, 2025 | 6.8% | +0.8 |
| Q3 FY2025 | Sep 30, 2025 | 14.5% | +10.7 |
| Q2 FY2025 | Jun 30, 2025 | 8.4% | +38.7 |
| Q1 FY2025 | Mar 31, 2025 | 4.5% | +3.7 |
| Q4 FY2024 | Dec 31, 2024 | 6.1% | +31.1 |
| Q3 FY2024 | Sep 30, 2024 | 3.8% | −0.4 |
| Q2 FY2024 | Jun 30, 2024 | -30.3% | −36.0 |
| Q1 FY2024 | Mar 31, 2024 | 0.8% | −2.1 |
| Q4 FY2023 | Dec 31, 2023 | -25.0% | −30.8 |
| Q3 FY2023 | Sep 30, 2023 | 4.2% | −2.0 |
| Q2 FY2023 | Jun 30, 2023 | 5.6% | +0.1 |
| Q1 FY2023 | Mar 31, 2023 | 2.9% | +7.3 |
| Q4 FY2022 | Dec 31, 2022 | 5.8% | −3.8 |
| Q3 FY2022 | Sep 30, 2022 | 6.3% | +0.0 |
| Q2 FY2022 | Jun 30, 2022 | 5.6% | −1.8 |
| Q1 FY2022 | Mar 31, 2022 | -4.4% | −8.3 |
| Q4 FY2021 | Dec 31, 2021 | 9.5% | +25.0 |
| Q3 FY2021 | Sep 30, 2021 | 6.2% | +15.2 |
| Q2 FY2021 | Jun 30, 2021 | 7.4% | +169.3 |
| Q1 FY2021 | Mar 31, 2021 | 3.9% | +8.2 |
| Q4 FY2020 | Dec 31, 2020 | -15.4% | −17.5 |
| Q3 FY2020 | Sep 30, 2020 | -8.9% | +267.2 |
| Q2 FY2020 | Jun 30, 2020 | -161.9% | −160.0 |
| Q1 FY2020 | Mar 31, 2020 | -4.2% | +52.6 |
| Q4 FY2019 | Dec 31, 2019 | 2.0% | −4.7 |
| Q3 FY2019 | Sep 30, 2019 | -276.1% | −283.8 |
| Q2 FY2019 | Jun 30, 2019 | -1.9% | −11.1 |
| Q1 FY2019 | Mar 31, 2019 | -56.9% | −64.3 |
| Q4 FY2018 | Dec 31, 2018 | 6.8% | −8.2 |
| Q3 FY2018 | Sep 30, 2018 | 7.7% | +0.1 |
| Q2 FY2018 | Jun 30, 2018 | 9.2% | +1.6 |
| Q1 FY2018 | Mar 31, 2018 | 7.4% | +0.9 |
| Q4 FY2017 | Dec 31, 2017 | 14.9% | – |
| Q3 FY2017 | Sep 30, 2017 | 7.6% | – |
| Q2 FY2017 | Jun 30, 2017 | 7.6% | – |
| Q1 FY2017 | Mar 31, 2017 | 6.5% | – |
See a number that looks wrong?